nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Niclosamide—STAT3—pancreatic cancer	0.0248	0.725	CrCbGaD
Tolcapone—Tolmetin—CXCL8—pancreatic cancer	0.00728	0.213	CrCbGaD
Tolcapone—CYP2C9—Tamoxifen—pancreatic cancer	0.00706	0.576	CbGbCtD
Tolcapone—CYP2C9—Fluorouracil—pancreatic cancer	0.00521	0.424	CbGbCtD
Tolcapone—Tolmetin—PTGS2—pancreatic cancer	0.00212	0.0621	CrCbGaD
Tolcapone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000565	0.000593	CcSEcCtD
Tolcapone—Palpitations—Docetaxel—pancreatic cancer	0.000559	0.000586	CcSEcCtD
Tolcapone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000556	0.000583	CcSEcCtD
Tolcapone—Weight decreased—Epirubicin—pancreatic cancer	0.000554	0.000581	CcSEcCtD
Tolcapone—Cough—Docetaxel—pancreatic cancer	0.000552	0.000579	CcSEcCtD
Tolcapone—Angina pectoris—Doxorubicin—pancreatic cancer	0.000552	0.000578	CcSEcCtD
Tolcapone—Hypersensitivity—Irinotecan—pancreatic cancer	0.00055	0.000577	CcSEcCtD
Tolcapone—Pneumonia—Epirubicin—pancreatic cancer	0.000549	0.000576	CcSEcCtD
Tolcapone—Hypertension—Docetaxel—pancreatic cancer	0.000546	0.000572	CcSEcCtD
Tolcapone—Infestation—Epirubicin—pancreatic cancer	0.000546	0.000572	CcSEcCtD
Tolcapone—Infestation NOS—Epirubicin—pancreatic cancer	0.000546	0.000572	CcSEcCtD
Tolcapone—Bronchitis—Doxorubicin—pancreatic cancer	0.000545	0.000571	CcSEcCtD
Tolcapone—Arthralgia—Docetaxel—pancreatic cancer	0.000538	0.000564	CcSEcCtD
Tolcapone—Myalgia—Docetaxel—pancreatic cancer	0.000538	0.000564	CcSEcCtD
Tolcapone—Chest pain—Docetaxel—pancreatic cancer	0.000538	0.000564	CcSEcCtD
Tolcapone—Nausea—Sunitinib—pancreatic cancer	0.000538	0.000564	CcSEcCtD
Tolcapone—Asthenia—Irinotecan—pancreatic cancer	0.000536	0.000562	CcSEcCtD
Tolcapone—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000535	0.000561	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000535	0.000561	CcSEcCtD
Tolcapone—Stomatitis—Epirubicin—pancreatic cancer	0.000532	0.000558	CcSEcCtD
Tolcapone—Urinary tract infection—Epirubicin—pancreatic cancer	0.00053	0.000556	CcSEcCtD
Tolcapone—Dysuria—Doxorubicin—pancreatic cancer	0.000529	0.000555	CcSEcCtD
Tolcapone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000527	0.000552	CcSEcCtD
Tolcapone—Dry mouth—Docetaxel—pancreatic cancer	0.000526	0.000552	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000526	0.000552	CcSEcCtD
Tolcapone—Sweating—Epirubicin—pancreatic cancer	0.000523	0.000549	CcSEcCtD
Tolcapone—Pollakiuria—Doxorubicin—pancreatic cancer	0.000523	0.000549	CcSEcCtD
Tolcapone—Asthenia—Gemcitabine—pancreatic cancer	0.000522	0.000547	CcSEcCtD
Tolcapone—Haematuria—Epirubicin—pancreatic cancer	0.00052	0.000546	CcSEcCtD
Tolcapone—Confusional state—Docetaxel—pancreatic cancer	0.00052	0.000546	CcSEcCtD
Tolcapone—Oedema—Docetaxel—pancreatic cancer	0.000516	0.000541	CcSEcCtD
Tolcapone—Epistaxis—Epirubicin—pancreatic cancer	0.000515	0.00054	CcSEcCtD
Tolcapone—Pruritus—Gemcitabine—pancreatic cancer	0.000514	0.000539	CcSEcCtD
Tolcapone—Infection—Docetaxel—pancreatic cancer	0.000513	0.000538	CcSEcCtD
Tolcapone—Weight decreased—Doxorubicin—pancreatic cancer	0.000512	0.000537	CcSEcCtD
Tolcapone—Sinusitis—Epirubicin—pancreatic cancer	0.000512	0.000537	CcSEcCtD
Tolcapone—Diarrhoea—Irinotecan—pancreatic cancer	0.000511	0.000536	CcSEcCtD
Tolcapone—Pneumonia—Doxorubicin—pancreatic cancer	0.000508	0.000533	CcSEcCtD
Tolcapone—Shock—Docetaxel—pancreatic cancer	0.000508	0.000532	CcSEcCtD
Tolcapone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000506	0.000531	CcSEcCtD
Tolcapone—Pruritus—Fluorouracil—pancreatic cancer	0.000506	0.00053	CcSEcCtD
Tolcapone—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000505	0.00053	CcSEcCtD
Tolcapone—Infestation NOS—Doxorubicin—pancreatic cancer	0.000505	0.000529	CcSEcCtD
Tolcapone—Infestation—Doxorubicin—pancreatic cancer	0.000505	0.000529	CcSEcCtD
Tolcapone—Tachycardia—Docetaxel—pancreatic cancer	0.000504	0.000528	CcSEcCtD
Tolcapone—Skin disorder—Docetaxel—pancreatic cancer	0.000501	0.000526	CcSEcCtD
Tolcapone—Bradycardia—Epirubicin—pancreatic cancer	0.000499	0.000523	CcSEcCtD
Tolcapone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000497	0.000522	CcSEcCtD
Tolcapone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000495	0.000519	CcSEcCtD
Tolcapone—Dizziness—Irinotecan—pancreatic cancer	0.000494	0.000518	CcSEcCtD
Tolcapone—Haemoglobin—Epirubicin—pancreatic cancer	0.000492	0.000516	CcSEcCtD
Tolcapone—Stomatitis—Doxorubicin—pancreatic cancer	0.000492	0.000516	CcSEcCtD
Tolcapone—Anorexia—Docetaxel—pancreatic cancer	0.000492	0.000516	CcSEcCtD
Tolcapone—Rhinitis—Epirubicin—pancreatic cancer	0.000491	0.000515	CcSEcCtD
Tolcapone—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000491	0.000515	CcSEcCtD
Tolcapone—Haemorrhage—Epirubicin—pancreatic cancer	0.00049	0.000514	CcSEcCtD
Tolcapone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000489	0.000513	CcSEcCtD
Tolcapone—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000487	0.000511	CcSEcCtD
Tolcapone—Pharyngitis—Epirubicin—pancreatic cancer	0.000486	0.00051	CcSEcCtD
Tolcapone—Sweating—Doxorubicin—pancreatic cancer	0.000484	0.000508	CcSEcCtD
Tolcapone—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000484	0.000507	CcSEcCtD
Tolcapone—Oedema peripheral—Epirubicin—pancreatic cancer	0.000483	0.000506	CcSEcCtD
Tolcapone—Hypotension—Docetaxel—pancreatic cancer	0.000482	0.000506	CcSEcCtD
Tolcapone—Haematuria—Doxorubicin—pancreatic cancer	0.000481	0.000505	CcSEcCtD
Tolcapone—Urethral disorder—Epirubicin—pancreatic cancer	0.00048	0.000504	CcSEcCtD
Tolcapone—Epistaxis—Doxorubicin—pancreatic cancer	0.000476	0.000499	CcSEcCtD
Tolcapone—Vomiting—Irinotecan—pancreatic cancer	0.000475	0.000498	CcSEcCtD
Tolcapone—Sinusitis—Doxorubicin—pancreatic cancer	0.000474	0.000497	CcSEcCtD
Tolcapone—Dizziness—Fluorouracil—pancreatic cancer	0.000473	0.000496	CcSEcCtD
Tolcapone—Rash—Irinotecan—pancreatic cancer	0.000471	0.000494	CcSEcCtD
Tolcapone—Dermatitis—Irinotecan—pancreatic cancer	0.00047	0.000493	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00047	0.000493	CcSEcCtD
Tolcapone—Headache—Irinotecan—pancreatic cancer	0.000468	0.00049	CcSEcCtD
Tolcapone—Paraesthesia—Docetaxel—pancreatic cancer	0.000463	0.000486	CcSEcCtD
Tolcapone—Erythema multiforme—Epirubicin—pancreatic cancer	0.000463	0.000486	CcSEcCtD
Tolcapone—Vomiting—Gemcitabine—pancreatic cancer	0.000462	0.000485	CcSEcCtD
Tolcapone—Bradycardia—Doxorubicin—pancreatic cancer	0.000461	0.000484	CcSEcCtD
Tolcapone—Dyspnoea—Docetaxel—pancreatic cancer	0.00046	0.000482	CcSEcCtD
Tolcapone—Somnolence—Docetaxel—pancreatic cancer	0.000459	0.000481	CcSEcCtD
Tolcapone—Rash—Gemcitabine—pancreatic cancer	0.000458	0.000481	CcSEcCtD
Tolcapone—Dermatitis—Gemcitabine—pancreatic cancer	0.000458	0.00048	CcSEcCtD
Tolcapone—Tinnitus—Epirubicin—pancreatic cancer	0.000457	0.000479	CcSEcCtD
Tolcapone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000456	0.000478	CcSEcCtD
Tolcapone—Headache—Gemcitabine—pancreatic cancer	0.000455	0.000478	CcSEcCtD
Tolcapone—Vomiting—Fluorouracil—pancreatic cancer	0.000455	0.000477	CcSEcCtD
Tolcapone—Rhinitis—Doxorubicin—pancreatic cancer	0.000454	0.000477	CcSEcCtD
Tolcapone—Dyspepsia—Docetaxel—pancreatic cancer	0.000454	0.000476	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000453	0.000475	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000451	0.000473	CcSEcCtD
Tolcapone—Rash—Fluorouracil—pancreatic cancer	0.000451	0.000473	CcSEcCtD
Tolcapone—Dermatitis—Fluorouracil—pancreatic cancer	0.00045	0.000472	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—pancreatic cancer	0.00045	0.000472	CcSEcCtD
Tolcapone—Decreased appetite—Docetaxel—pancreatic cancer	0.000449	0.00047	CcSEcCtD
Tolcapone—Headache—Fluorouracil—pancreatic cancer	0.000448	0.00047	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000448	0.000469	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000446	0.000468	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000445	0.000467	CcSEcCtD
Tolcapone—Fatigue—Docetaxel—pancreatic cancer	0.000445	0.000467	CcSEcCtD
Tolcapone—Angiopathy—Epirubicin—pancreatic cancer	0.000444	0.000466	CcSEcCtD
Tolcapone—Urethral disorder—Doxorubicin—pancreatic cancer	0.000444	0.000466	CcSEcCtD
Tolcapone—Nausea—Irinotecan—pancreatic cancer	0.000443	0.000465	CcSEcCtD
Tolcapone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000441	0.000463	CcSEcCtD
Tolcapone—Constipation—Docetaxel—pancreatic cancer	0.000441	0.000463	CcSEcCtD
Tolcapone—Pain—Docetaxel—pancreatic cancer	0.000441	0.000463	CcSEcCtD
Tolcapone—Chills—Epirubicin—pancreatic cancer	0.00044	0.000461	CcSEcCtD
Tolcapone—Arrhythmia—Epirubicin—pancreatic cancer	0.000438	0.000459	CcSEcCtD
Tolcapone—Alopecia—Epirubicin—pancreatic cancer	0.000433	0.000454	CcSEcCtD
Tolcapone—Nausea—Gemcitabine—pancreatic cancer	0.000432	0.000453	CcSEcCtD
Tolcapone—Mental disorder—Epirubicin—pancreatic cancer	0.000429	0.00045	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000429	0.000449	CcSEcCtD
Tolcapone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000425	0.000446	CcSEcCtD
Tolcapone—Nausea—Fluorouracil—pancreatic cancer	0.000425	0.000445	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—pancreatic cancer	0.000423	0.000443	CcSEcCtD
Tolcapone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000422	0.000442	CcSEcCtD
Tolcapone—Flatulence—Epirubicin—pancreatic cancer	0.00042	0.000441	CcSEcCtD
Tolcapone—Tension—Epirubicin—pancreatic cancer	0.000418	0.000439	CcSEcCtD
Tolcapone—Dysgeusia—Epirubicin—pancreatic cancer	0.000418	0.000438	CcSEcCtD
Tolcapone—Nervousness—Epirubicin—pancreatic cancer	0.000414	0.000434	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—pancreatic cancer	0.000411	0.000431	CcSEcCtD
Tolcapone—Muscle spasms—Epirubicin—pancreatic cancer	0.00041	0.00043	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000408	0.000428	CcSEcCtD
Tolcapone—Body temperature increased—Docetaxel—pancreatic cancer	0.000408	0.000428	CcSEcCtD
Tolcapone—Abdominal pain—Docetaxel—pancreatic cancer	0.000408	0.000428	CcSEcCtD
Tolcapone—Chills—Doxorubicin—pancreatic cancer	0.000407	0.000426	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—pancreatic cancer	0.000405	0.000425	CcSEcCtD
Tolcapone—Vision blurred—Epirubicin—pancreatic cancer	0.000402	0.000421	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—pancreatic cancer	0.000401	0.00042	CcSEcCtD
Tolcapone—Mental disorder—Doxorubicin—pancreatic cancer	0.000397	0.000416	CcSEcCtD
Tolcapone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000396	0.000415	CcSEcCtD
Tolcapone—Anaemia—Epirubicin—pancreatic cancer	0.000394	0.000413	CcSEcCtD
Tolcapone—Agitation—Epirubicin—pancreatic cancer	0.000392	0.000411	CcSEcCtD
Tolcapone—Flatulence—Doxorubicin—pancreatic cancer	0.000389	0.000408	CcSEcCtD
Tolcapone—Tension—Doxorubicin—pancreatic cancer	0.000387	0.000406	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—pancreatic cancer	0.000386	0.000405	CcSEcCtD
Tolcapone—Malaise—Epirubicin—pancreatic cancer	0.000385	0.000403	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—pancreatic cancer	0.000383	0.000402	CcSEcCtD
Tolcapone—Vertigo—Epirubicin—pancreatic cancer	0.000383	0.000402	CcSEcCtD
Tolcapone—Syncope—Epirubicin—pancreatic cancer	0.000382	0.000401	CcSEcCtD
Tolcapone—Hypersensitivity—Docetaxel—pancreatic cancer	0.00038	0.000399	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—pancreatic cancer	0.000379	0.000398	CcSEcCtD
Tolcapone—Palpitations—Epirubicin—pancreatic cancer	0.000377	0.000395	CcSEcCtD
Tolcapone—Loss of consciousness—Epirubicin—pancreatic cancer	0.000375	0.000393	CcSEcCtD
Tolcapone—Cough—Epirubicin—pancreatic cancer	0.000372	0.00039	CcSEcCtD
Tolcapone—Vision blurred—Doxorubicin—pancreatic cancer	0.000372	0.00039	CcSEcCtD
Tolcapone—Asthenia—Docetaxel—pancreatic cancer	0.00037	0.000388	CcSEcCtD
Tolcapone—Hypertension—Epirubicin—pancreatic cancer	0.000368	0.000386	CcSEcCtD
Tolcapone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000366	0.000384	CcSEcCtD
Tolcapone—Pruritus—Docetaxel—pancreatic cancer	0.000365	0.000383	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—pancreatic cancer	0.000365	0.000382	CcSEcCtD
Tolcapone—Arthralgia—Epirubicin—pancreatic cancer	0.000363	0.000381	CcSEcCtD
Tolcapone—Chest pain—Epirubicin—pancreatic cancer	0.000363	0.000381	CcSEcCtD
Tolcapone—Myalgia—Epirubicin—pancreatic cancer	0.000363	0.000381	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—pancreatic cancer	0.000363	0.00038	CcSEcCtD
Tolcapone—Anxiety—Epirubicin—pancreatic cancer	0.000362	0.000379	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000361	0.000378	CcSEcCtD
Tolcapone—Discomfort—Epirubicin—pancreatic cancer	0.000359	0.000376	CcSEcCtD
Tolcapone—Malaise—Doxorubicin—pancreatic cancer	0.000356	0.000373	CcSEcCtD
Tolcapone—Dry mouth—Epirubicin—pancreatic cancer	0.000355	0.000372	CcSEcCtD
Tolcapone—Vertigo—Doxorubicin—pancreatic cancer	0.000354	0.000372	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—pancreatic cancer	0.000354	0.000371	CcSEcCtD
Tolcapone—Diarrhoea—Docetaxel—pancreatic cancer	0.000353	0.00037	CcSEcCtD
Tolcapone—Confusional state—Epirubicin—pancreatic cancer	0.000351	0.000368	CcSEcCtD
Tolcapone—Palpitations—Doxorubicin—pancreatic cancer	0.000349	0.000366	CcSEcCtD
Tolcapone—Oedema—Epirubicin—pancreatic cancer	0.000348	0.000365	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000347	0.000364	CcSEcCtD
Tolcapone—Infection—Epirubicin—pancreatic cancer	0.000346	0.000363	CcSEcCtD
Tolcapone—Cough—Doxorubicin—pancreatic cancer	0.000344	0.000361	CcSEcCtD
Tolcapone—Shock—Epirubicin—pancreatic cancer	0.000342	0.000359	CcSEcCtD
Tolcapone—Nervous system disorder—Epirubicin—pancreatic cancer	0.000341	0.000358	CcSEcCtD
Tolcapone—Dizziness—Docetaxel—pancreatic cancer	0.000341	0.000358	CcSEcCtD
Tolcapone—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000341	0.000357	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—pancreatic cancer	0.000341	0.000357	CcSEcCtD
Tolcapone—Tachycardia—Epirubicin—pancreatic cancer	0.00034	0.000356	CcSEcCtD
Tolcapone—Skin disorder—Epirubicin—pancreatic cancer	0.000338	0.000355	CcSEcCtD
Tolcapone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000336	0.000353	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—pancreatic cancer	0.000336	0.000352	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—pancreatic cancer	0.000336	0.000352	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—pancreatic cancer	0.000336	0.000352	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—pancreatic cancer	0.000335	0.000351	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000334	0.00035	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—pancreatic cancer	0.000332	0.000348	CcSEcCtD
Tolcapone—Anorexia—Epirubicin—pancreatic cancer	0.000332	0.000348	CcSEcCtD
Tolcapone—Dry mouth—Doxorubicin—pancreatic cancer	0.000329	0.000345	CcSEcCtD
Tolcapone—Vomiting—Docetaxel—pancreatic cancer	0.000328	0.000344	CcSEcCtD
Tolcapone—Rash—Docetaxel—pancreatic cancer	0.000325	0.000341	CcSEcCtD
Tolcapone—Hypotension—Epirubicin—pancreatic cancer	0.000325	0.000341	CcSEcCtD
Tolcapone—Dermatitis—Docetaxel—pancreatic cancer	0.000325	0.000341	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—pancreatic cancer	0.000325	0.000341	CcSEcCtD
Tolcapone—Headache—Docetaxel—pancreatic cancer	0.000323	0.000339	CcSEcCtD
Tolcapone—Oedema—Doxorubicin—pancreatic cancer	0.000322	0.000338	CcSEcCtD
Tolcapone—Infection—Doxorubicin—pancreatic cancer	0.00032	0.000335	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000317	0.000333	CcSEcCtD
Tolcapone—Shock—Doxorubicin—pancreatic cancer	0.000317	0.000332	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000316	0.000331	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000315	0.000331	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—pancreatic cancer	0.000314	0.00033	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—pancreatic cancer	0.000313	0.000328	CcSEcCtD
Tolcapone—Paraesthesia—Epirubicin—pancreatic cancer	0.000312	0.000328	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000311	0.000326	CcSEcCtD
Tolcapone—Dyspnoea—Epirubicin—pancreatic cancer	0.00031	0.000325	CcSEcCtD
Tolcapone—Somnolence—Epirubicin—pancreatic cancer	0.000309	0.000324	CcSEcCtD
Tolcapone—Anorexia—Doxorubicin—pancreatic cancer	0.000307	0.000322	CcSEcCtD
Tolcapone—Nausea—Docetaxel—pancreatic cancer	0.000306	0.000321	CcSEcCtD
Tolcapone—Dyspepsia—Epirubicin—pancreatic cancer	0.000306	0.000321	CcSEcCtD
Tolcapone—Decreased appetite—Epirubicin—pancreatic cancer	0.000303	0.000317	CcSEcCtD
Tolcapone—Hypotension—Doxorubicin—pancreatic cancer	0.000301	0.000316	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.0003	0.000315	CcSEcCtD
Tolcapone—Fatigue—Epirubicin—pancreatic cancer	0.0003	0.000315	CcSEcCtD
Tolcapone—Constipation—Epirubicin—pancreatic cancer	0.000298	0.000312	CcSEcCtD
Tolcapone—Pain—Epirubicin—pancreatic cancer	0.000298	0.000312	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000293	0.000308	CcSEcCtD
Tolcapone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000289	0.000303	CcSEcCtD
Tolcapone—Dyspnoea—Doxorubicin—pancreatic cancer	0.000287	0.000301	CcSEcCtD
Tolcapone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000287	0.000301	CcSEcCtD
Tolcapone—Somnolence—Doxorubicin—pancreatic cancer	0.000286	0.0003	CcSEcCtD
Tolcapone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000285	0.000298	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000283	0.000297	CcSEcCtD
Tolcapone—Decreased appetite—Doxorubicin—pancreatic cancer	0.00028	0.000294	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000278	0.000292	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—pancreatic cancer	0.000278	0.000291	CcSEcCtD
Tolcapone—Urticaria—Epirubicin—pancreatic cancer	0.000276	0.00029	CcSEcCtD
Tolcapone—Pain—Doxorubicin—pancreatic cancer	0.000275	0.000289	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—pancreatic cancer	0.000275	0.000289	CcSEcCtD
Tolcapone—Abdominal pain—Epirubicin—pancreatic cancer	0.000275	0.000289	CcSEcCtD
Tolcapone—Body temperature increased—Epirubicin—pancreatic cancer	0.000275	0.000289	CcSEcCtD
Tolcapone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000265	0.000278	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000263	0.000276	CcSEcCtD
Tolcapone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000256	0.000269	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—pancreatic cancer	0.000256	0.000268	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000255	0.000267	CcSEcCtD
Tolcapone—Body temperature increased—Doxorubicin—pancreatic cancer	0.000255	0.000267	CcSEcCtD
Tolcapone—Asthenia—Epirubicin—pancreatic cancer	0.00025	0.000262	CcSEcCtD
Tolcapone—Pruritus—Epirubicin—pancreatic cancer	0.000246	0.000258	CcSEcCtD
Tolcapone—Diarrhoea—Epirubicin—pancreatic cancer	0.000238	0.00025	CcSEcCtD
Tolcapone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000237	0.000249	CcSEcCtD
Tolcapone—Asthenia—Doxorubicin—pancreatic cancer	0.000231	0.000242	CcSEcCtD
Tolcapone—Dizziness—Epirubicin—pancreatic cancer	0.00023	0.000241	CcSEcCtD
Tolcapone—Pruritus—Doxorubicin—pancreatic cancer	0.000228	0.000239	CcSEcCtD
Tolcapone—Vomiting—Epirubicin—pancreatic cancer	0.000221	0.000232	CcSEcCtD
Tolcapone—Diarrhoea—Doxorubicin—pancreatic cancer	0.00022	0.000231	CcSEcCtD
Tolcapone—Rash—Epirubicin—pancreatic cancer	0.000219	0.00023	CcSEcCtD
Tolcapone—Dermatitis—Epirubicin—pancreatic cancer	0.000219	0.00023	CcSEcCtD
Tolcapone—Headache—Epirubicin—pancreatic cancer	0.000218	0.000229	CcSEcCtD
Tolcapone—Dizziness—Doxorubicin—pancreatic cancer	0.000213	0.000223	CcSEcCtD
Tolcapone—Nausea—Epirubicin—pancreatic cancer	0.000207	0.000217	CcSEcCtD
Tolcapone—Vomiting—Doxorubicin—pancreatic cancer	0.000205	0.000215	CcSEcCtD
Tolcapone—Rash—Doxorubicin—pancreatic cancer	0.000203	0.000213	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—pancreatic cancer	0.000203	0.000213	CcSEcCtD
Tolcapone—Headache—Doxorubicin—pancreatic cancer	0.000202	0.000212	CcSEcCtD
Tolcapone—Nausea—Doxorubicin—pancreatic cancer	0.000191	0.000201	CcSEcCtD
